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Although the antibodies responsible in vivo for the immunosuppressive  action 
of  anti-lymphocyte serum  (ALS)  are  of  IgG specificity (1,  2),  only a  small 
fraction of the total IgG is effectively anti-lymphocytic. Lance (2) and Wood- 
ruff et al. (3) have estimated by absorption studies of radioactive ALS IgG that 
the relevant antibodies comprise between 1-5 %  of the total serum IgG. The 
importance of this observation becomes apparent when attempts are made to 
trace the fate of the active component, since the results may well by obscured by 
the 95 % IgG irrelevant to the action of ALS: In order to study the natural his- 
tory of the relevant molecules as a means of gaining insight into the mechanism 
of action of ALS, it was deemed necessary to enrich the specificity of the prep- 
aration. In this communication the method used to achieve this end and the 
results of study of the product obtained will be described. 
Materials and Methods 
Animals.--Mice were obtained from the breeding unit at the National Institute for Medical 
Research, Mill Hill, Londo 1, England,  and included the inbred strain of CBA and outbred 
strains of Tyler, VS, or Parkes mice. The outbred animals were used as  a source of thymus 
in the production of ALS. 
Preparation of ALS.--Adult New Zealand White rabbits received two intravenous injec- 
tions of 1 X  109 mouse thymocytes 2 wk apart.  1 wk later they were exsanguinated from the 
heart and the pooled serum was inactivated at 56°C for 30 min, sterilized by Seitz filtration and 
stored at --20°C until use (4). 
Isolation of IgG.--The crude globulin was extracted  from samples of whole serum by am- 
monium sulfate precipitation  (5) and after equilibration with the appropriate buffer, the IgG 
component was isolated by column chromatography on DEAE-cellulose  1 (6). Protein concen- 
trations were determined by spectrophotometry with a Unicam spectrophotometer reading at 
280 m~u (extinction coefficient  for gamma globulin = 14 for a 1% solution). The purity of the 
preparations were checked by immunoelectrophoresis (7) using goat anti whole rabbit serum 
and goat anti rabbit IgG Fc piece (kindly supplied by Dr. Sayaka Utsumi). 
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1 DEAE-cellulose, diethylaminoethyl cellulose. 
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lodinatlon of Proteins.--Proteins were labeled with either carrier free laI or 1~5I (Radio- 
chemicals-Amersham, England) by the method of McFarlane (8). 
Preparation of Eluate.--The general scheme was to cause samples of ALS IgG to react with 
acid-washed "membrane" preparations of thymocytes, to elute the "anti-lymphocytic" anti- 
body in the presence of acid pH and to recover the enriched product (ELX)  after passage 
through DEAE-cellulose. A stepwise description of the procedure will be followed by a typical 
protocol. 
1. Preparation of Thymocyte "Membrane".--Initially, whole thymocytes  were used to absorb 
ELX from ALS IgG. However, it was found that the acid elution step released great quantities 
of extraneous cell material into the supernatant, thus making subsequent isolation of IgG more 
difficult.  Formalized cells had the disadvantage of increasing the nonspecific absorption. A 
membrane preparation  ("crude  insoluble"  lipoprotein fraction)  (9)  of  mouse  thymocytes 
proved an efficient absorbing material but again released troublesome material into the eluate. 
Pretreatment of the "membrane" with 0.1 u citric acid (pH 2.5) for 60 min largely eliminated 
this difficulty, although some loss of absorbing ability was associated with this step. The acid 
washed membrane could be stored at 4°C under strong salt (3.0 M) or at --20°C, and preserved 
absorption potency. 
2. Reaction of Membrane  with ALS IgG.---The ALS IgG preparations were sometimes trace 
labeled with l~JI during the initial runs when optimum conditions were being sought. The final 
protein concentration was adjusted to 2 mg/ml and the ALS IgG and membrane were mixed at 
a ratio of between 0.5 to 1.0 mg of IgG per membrane yield of 10  '~ thymocytes. This ratio pro- 
vided maximum specific binding and allowed final recovery of ELX representing about 2% of 
the original IgG sample. After incubation in a water bath for 30 rain at 37°C  the mixture was 
spun at 25,000 rpm in a model L  Spinco Ultracentrifuge using an SW 25 rotor for 1 hr. The 
supernatant was discarded (or portion kept for determination of residual radioactivity) and 
the sediment washed 3X  in phosphate buffered saline (PBS),  pH 7.2, by resuspending in  a 
hand homogenizer with interval centrifugation as above. 
3. Elution Step.--After the last spin the sediment was resuspended by hand homogenization 
in approximately 40 ml of 0.1 M citric acid (pH 2.5) and placed at 4°C with constant magnetic 
stirring for 30 rain. The mixture was then centrifuged as above and the supernatant collected. 
(In those experiments where the method was evaluated, samples of the supernatant and sedi- 
ment were counted for residual radioactivity.) The eluate was placed in Visking dialysis tubing 
and pressure dialyzed against PBS (pH 7.2) to equilibrium and to a final volume of about 5 ml. 
Initially the eluate was neutralized by the dropwise addition of 0.5 N NaOH, but it is our im- 
pression that denaturation was greater than through the slower neutralization achieved by 
dialysis.  After neutralization a small amount of precipitate was usually noted and was removed 
by centrifugation. 
4. Recovery of IgG molec~des  from Eluate.--The neutralized eluate was dialyzed against 0.02 
M phosphate buffer (pH 8.0) overnight and then placed on a DEAE-cellulose column and the 
IgG molecules eluted with 0.02 M phosphate (pH 7.4). The final eluate was concentrated by 
pressure and dialysis against PBS  (pH. 7.2),  sterilized by Millipore filtration, and stored at 
--20°C. The protein concentration was determined by spectrophotometry. 
Protocol.--1.  The  membrane fraction was prepared from thymocytes of  500  mice  (wet 
weight 30.4 g) and exposed to 0.1 M citric acid (pH 2.5) for 60 rain. The sediment was washed 
2 X  in PBS. 
2.  5 mg of ALS IgG were trace-labeled with 131I (100 #c with 50% efficiency)  and added 
to 45 mg of ALS IgG at a final concentration of 2 mg/ml, i.e., 25 ml total volume. A 0.1 ml 
portion was set aside as a standard. 
3. The acid washed membrane and the ALS IgG solution were then thoroughly mixed and 
placed in a 37°C water bath with agitation for 30 min. The sediment was washed 3 X  in PBS. EUGENE M. LANCE  51 
4. The sediment was resuspended in 40 ml of 0.1 ~t citric acid and stirred in the cold for 30 
min. After centrifugation the sediment and the supernatant  were  collected. The supernatant was 
pressure dialyzed against PBS overnight to a final volume of 10 ml with the formation of a 
slight precipitate. The sample was centrifuged at 3000 g and the precipitate and supernatant 
collected. At this stage the radioactivity in the eluate supernatant indicated that it contained 
1.3 mg of IgG but the optical density at 280 m# indicated that the total protein content was 
about 2.4 mg. Therefore, approximately 1.1 mg of contaminating protein was present which 
had been released from the membrane substance itself. 
5. The eluate was equilibrated against 0.02  ~t phosphate (pH 8.0)  and passed through a 
DEAE-cellulose column using 0.02 ~t phosphate pH 7.4 buffer. The column consisted of a 10 
ml plastic syringe containing 4 ml of DEAE-celfulose (Whatman Chromedia DE-32). 100 drop 
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FIG. 1. See text for explanation 
samples were collected and the concentration of IgG was monitored by determing the radio- 
activity in the fractions (Fig.  1). After 50 tubes had been collected, the buffer was changed to 
0.05 ~ phosphate and an additional 35 tubes collected. This ensured that all the protein had 
been removed from the column. Tubes 4-10 containing the first peak were pooled and pressure 
dialyzed versus PBS to a final volume of 3.0 ml. 
6. Counting the original standard, the sediment membrane, the precipitate, and the final 
ELK preparation for residual radioactivity allowed calculation of the percentage of IgG to be 
found at various stages. In this run, the final recovery of ALS IgG as ELX was 1.9%. The 
amount of protein bound to membrane but not eluted was 1.0%, and the amount of protein 
lost as precipitate after neutralization of eluate was 0.2%. Small amounts of IgG were also, of 
course, lost on the column and in the discarded fractions eluted from DEAE. The total protein 
contained in the final preparation was 1.0 mg, as estimated by optical density measurement 
(2.0% of the original sample) and this excellent agreement between the determinations by 
radioactivity and optical density indicates that very little if any contaminant was present in 
the final preparation. 52  ACTION  OF  ANTI-LYMPHOCYTE  SERUM 
RESULTS 
Characterization of ELX.--1.  hnmunoelectrophoresis  of the enriched  eluate 
(ELX)  solutions showed  a  single  arc  of precipitation  in  the  IgG region.  The 
ELX appeared to be a more homogeneous substance as compared with the arc 
found against whole ALS IgG (Fig. 2). 
2. Samples of ELX were run on a sucrose gradient comparing the migration of 
the trace-labeled  ELX molecules with  those of native  rabbit  IgG. The results 
are shown in Fig. 3.20/~g of trace labeled ~3II ELX was added to 1.0 mg. of nor- 
mal rabbit IgG to which some mouse hemoglobin was added. This sample was 
placed on top of a  discontinuous sucrose gradient which had been prepared by 
FIG. 2. Immunoelectrophoresis of ELX (top well) and ALS IgG (bottom well) against goat 
anti whole rabbit  serum  (top  and bottom trough)  and  goat  anti rabbit  gamma  G  (middle 
trough).  The ALS IgG molecules appear to have a broader range of electrophoretic mobility 
than that found in the ELX subeomponent. 
layering consecutively 40%, 25 %, and 10% sucrose in volumes of 1.5 ml upon 
another. The plastic tube containing the gradient and sample was spun for 18 hr 
at 22°C in a model L Spinco ultracentrifuge at 35,000 rpm using an SW 39 rotor. 
Fractions of eight drops were collected from the bottom of the gradient and each 
fraction counted for residual  radioactivity and the optical density at  280 and 
575  m# determined.  The peak of radioactivity coincided fairly well with  that 
for  IgG  and  was  distinct  from  that  of hemoglobin  indicating  that  no  gross 
denaturation  was present. 
3. In vitro binding to lymphocyte membrane: 60 #g of '~'I trace labeled ELX 
containing 133,000 counts per minute was allowed to react at 37°C for 30 rain 
min  with  1.5  X  109  thymocytes prepared  from the  thymuses  of  10 A  strain 
mice. After centrifugation,  40 %  of the counts remained in the supernatant.  A 
second absorption with 1 X  109 cells was carried out in a similar manner and the EUOE~E  u.  LANCE  53 
second supernatant contained 25 % of the original counts. Therefore, with two 
exposures, 75 % of the molecules were removed from solution. Control experi- 
ments in which equivalent amounts of NRS IgG molecules were subjected to 
similar numbers of cells never gave more than 4-5 %  cumulative absorption. 
Therefore, the excess absorption of ELX molecules can be attributed to reten- 
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tion of antibody affinity for lymphocyte receptors. In retrospect, the amount of 
antigen provided was too low for the quantity of antibody to expect maximum 
absorption; (the optimum ratio for ALS IgG, roughly 109 cells/500 #g, must be 
multiplied by 30-40 for ELX). 
4. The ability of ELX preparations to kill lymphocytes in vitro in the presence 
of complement was determined by Dr. Marian Ruszkiewicz. When ELX II, at a 
concentration of 700 ~g per ml, was run in serial two dilutions, the cytotoxic 
end point titer was 1/4096 (Fig. 4). Comparing this to the titre of the parent 
antiserum XXI ALS IgG, and correcting for the difference in protein concen- 54  ACTION  O]~  ANTI-LYMPHOCYTE  SERUM 
tration we find that gram for gram, the ELX preparation is roughly 10 times 
more efficient in killing lymphocytes in vitro. 
5. Activity in vivo. the studies thus far have shown that ELX is composed of 
a relatively homogeneous population of IgG molecules which are not denatured 
to any great extent and which retain the ability to bind to and kill lymphocytes 
in vitro. However, ELX would prove useful only if it also retained the ability to 
prolong the survival of skin homografts. To conserve material, the assay used 
was based upon the studies of Jooste (10) who showed that the survival of skin 
homografts could be prolonged by the injection of newborn mice with small 
quantities of ALS whole serum. 10 newborn CBA mice received a subcutaneous 
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injection of 7 #g of ELX on the 1st and 23rd day of life and  17 #g on the llth 
day. On the 21st day these mice and five untreated control animals of the same 
age received an A strain tail skin graft. The survival times of the grafts on con- 
trols and ELX-treated mice are given in Fig. 5. The mean expectation of life 
has been prolonged from 9.5 days +1.7 to 14.0 4-2.1. The total amount of pro- 
tein given (31 #g IgG) represents approximately 1/a~0 of the dose that Jooste 
used  to  promote homograft survival in  this  strain  combination in a  similar 
though not identical protocol (10). 
6. Controls. Because we were concerned that acid exposure might denature 
the IgG molecules, two control experiments were performed to determine to 
what extent the preparation of ELX molecules results in a biologically different 
product. In the first experiment the effect of acid exposure on the potency of 
whole ALS was studied. 10 ml of whole ALS were divided into two 5 ml portions 
and one was dialyzed against 100 vol of 0.1 ~  citric acid (pH 2.5) for 2 hr, fol- ~UG~NE M-.  LANCe.  55 
lowed by dialysis 2X against 1000 volumes of PBS. The other portion was un- 
treated. Two groups of five CBA male mice were grafted with A strain tail skin. 
The first group received 0.5 ml of the untreated ALS subcutaneously on the 3rd 
and 5th postgraft day, whereas the second group received an equal quantity of 
the acid-exposed ALS. A slight but nonsignificant decrease in the mean survival 
time was noted for the group given acid-treated ALS. 
The second control measured the amount of denaturation induced by acid 
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FIG. 5. Comparing  the day to day survival of A strain skin homografts  on CBA mice which 
were either untreated (controls) or had received 31 gg of ELX subcutaneously. 
exposure through study of the rate of elimination of acid-treated NRS IgG in 
comparison with untreated NRS IgG. 7.5 mg NRS IgG (1.0 ml volume) was 
dialyzed vs. 2000 vol of 0.! M citric acid (pH 2.5) for 12 hr and then against 
2000 vol of PBS (pH 7.4) for 24 hr. Samples of NRS IgG and acid-treated NRS 
were labeled with mI and injected intraperitoneally into groups of six mice. The 
whole body counts were recorded daily. The rate of elimination for the two sam- 
ples was comparable (see Fig. 7, groups A and B). However, after acid exposure 
a precipitate had formed which was removed by centrifugation. By determina- 
tion of the protein content before and after acidification, approximately 20 % of 
the protein was grossly denatured. These two controls indicate that there is 
definite denaturation of protein by the exposure to low pH used in the enrich- 56  ACTION  OF  ANTI-LIrI~PHOCYTI~  SERIY~ 
ment procedure. However, even with prolonged exposure (12 hr in second con- 
trol) a minor fraction is affected, can be removed by centrifugation, and the re- 
mainder appears to be handled in vivo normally. The biological activity of the 
antibody fraction may be slightly reduced by this treatment, but if so, only in a 
minor way. 
Elimination of ELX from Recipient Animals.--The rate of elimination of spe- 
cific antibody from recipientmice was determined in four separate experiments, 
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FIG. 6. 16 CBA female mice received an intraperitoneal injection of mI libeled ELX II (80 
/~g/animal) and whole body counts were performed at I hr and 1, 2, 3, 4, 6, and 8 days there- 
after. The results are expressed as the average percentage of label remaining at the various 
times after appropriate corrections for background  and decay. The count at I  hr is taken as 
100%. 
using three different lots of ELX (Figs. 6 and 7). In some cases the material was 
administered  subcutaneously;  in  others,  intraperitoneally.  Other  variations 
were the inclusion of carrier whole ALS IgG in the inocuhm, or in some cases, 
the prior injection of whole ALS.  Controls  received both normal  and  acid- 
washed NRS IgG injections. On most occasions, iodide water was substituted 
for the normal drinking water of these animals 24 hr prior to injection. However, 
on one occasion, the substitution was not performed until the day of injection, 
with the result that the whole body retention reflected in part thyroid uptake 
and, therefore, gave somewhat higher values. Regardless of these differences, 
the trend is very clear. Whereas normal rabbit IgG (and ALS IgG as well) is ~.uGErrs  M.  z~Nc~.  57 
eliminated from the body exponentially with a half-life of between 5 and 6 days 
(roughly equivalent to that found for the elimination from the serum) the ELX 
molecules are much more rapidly cleared.  There appear  to be two phases to 
ELIMINATION  OF  ELUTED  ANTIBODY 
P 
Z 
O  u 
Z 
W 
U 
t¢ 
Ul 
0. 
20  410  60  BO  IOO  120  14(3  I~;;3  i~,J  ~LJu  :a~u  i 
HOURS 
FzG. 7. Each curve represents the average values of panels of 6 CBA females which received: 
A, •  •,  400/zg NRS IgG intraperitoneally;  B, O  O, 250/zg NRS IgG intraperi- 
toneally (exposed to acid, pH 2.5 for 12 hr before reneutralization);  C, []  [], 300/zg ELX 
III plus 0.5 cc whole ALS subcutaneously  (iodide water started  on day of injection);  D, 
H,  so ~g F~X  iV intraperitoneally;  E, •  •,  ELX as group D but 4 hr after 
0.5 cc whole ALS subcutaneously.  All preparations  were labeled with mI and whole body 
counts  were performed  immediately  after  injection  and at the indicated times thereafter. 
After correction for background and decay, the results  are  expressed as the average per cent 
radioactivity remaining at each interval  (time 0 =  100%). 
this clearance. During the first 24 hr about 70-80 %  of the molecules are elimi- 
nated, and from 24 hr onward the half-life of the remainder appears to be about 
24 hr. A  small fraction  (less  than  5 %)  of the original inoculum may remain 
within the body for a  considerably longer period and about 1-2 % may still be 
detected at the end of 1 wk (Fig. 6). 58  ACTION OF ANTI-LYMIPHOCYTE SERUM 
Distribution of ELX  in recipient animals.----Our initial studies attempting to 
define  the  tissue  localization of anti-lymphocyte antibody compared the  dis- 
tribution of labeled crude gamma globulin (GG) fractions (1.75 ~  ammonium 
sulfate precipitation) of NRS and ALS. 60 pg of 18~I  labeled ALS or NRS gamma 
globulin was injected into two groups of 30 mice subcutaneously in the right 
axilla. Five mice from each group were killed at 1, 2, 4, 24, 48, and 72 hr post- 
injection,  and the right and left axillary lymph nodes,  spleen,  thymus, and a 
TABLE I 
The Distribution in Mice of Labded Gamma Globulin from ALS or NRS 
Percentage uptake in cells 
Time 
R axillary noaes  L axillary nodes  Spleen  Thymus  Serum 
Group A 
1  0.69  0.02  0.01  0.01  1.1 
2  0.83  0.02  0.03  0.04  2.7 
4  0.31  0.02  0.04  0.02  4.9 
24  0.16  0.04  0.10  0.05  16.1 
48  0.05  0.04  0.09  0.06  12.8 
72  0.04  0.03  0.07  0.02  9.6 
Group B~t 
1  0.25  0.02  0.02  0.01  1.1 
2  0.77  0.01  0.02  0.03  2.8 
4  0.25  0.01  0.05  0.02  4.2 
24  0.12  0.04  0.09  0.06  10.0 
48  0.03  0.03  0.06  0.04  11.8 
72  0.04  0.03  0.06  0.03  11.5 
* GroupA consisted of 30 CBA male mice which received at time 60 ~g of ALS gamma 
G labeled with mI in 0.5 ml of NRS injected subcutaneously  into the right axilla. At each 
time interval 5 mice were killed and their organs removed for radioactive counting. 
Group B was treated in an identical fashion except that they received 60 ~g of NRS 
gamma B labeled with mI in 0.5 ml NRS. 
sample  of serum  removed for radioactive  counting  (Table  I).  No significant 
difference was discerned between the two groups with the possible exceptions of 
a greater uptake by the draining (R) nodes at 1 hr and a greater concentration 
of counts in the serum at 24 hr in animals receiving ALS GG. It is none the less 
apparent that neither of the two materials localizes in lymphoid organs to any 
great extent. 
In a second experiment of similar design (Table II) samples were collected at 
2 and 24 hr chosen to represent the time of maximal uptake in the draining node 
and the maximum concentration in the blood stream. In this case, however, cell 
suspensions were made from the various lymphoid organs and the leukocytes EUGENE..  LANCE  59 
were collected from the peripheral blood by  sedimentation  in  1.5 %  gelatin. 
These cell collections were then washed 3X in saline to get rid of non-cell-bound 
protein. It was hoped in this way to make obvious differences obscured in the 
first experiment by the presence of large  quantities  of protein  in  the  extra- 
cellular fluid. In all cases the mount of protein found on the ceils is quite small 
and of comparable orders of magnitude for the two groups with the one excep- 
tion that at 24 hr there is far more ALS globulin attached to the ceils of the 
draining node. Both experiments indicate that the localization of ALS  gamma 
globulin like NRS gamma globulin is minor in lymphoid organs and that the 
fate of any specific antibody is obscured by the abundance of extraneous protein. 
TABLE  II 
Distribution of Gamma Globulin from ALS or NRS in Mouse Lymphoid Cells 
Time  Percentage uptake in cells 
R axillary nodes  L axillary nodes  Peripheral leukocytes  Spleen 
Group A 
2  0.00  0.00  0.00  0.00 
24  0.02  0.003  0.01  0.04 
Group B 
2  0.008  0.01  0.00  0.00 
24  0.00  0.00  0.01  0.03 
CBA mice received 60 #g of t3tI labeled ALS gamma globulin (group A) or NRS gamma 
globulin (group B) suspended in 3% gelatin and injected into the right axilla at time 0. Five 
mice were killed at the specified  times and cell suspensions prepared from the lymph nodes 
of the right and left axilla, spleen and the peripheral leukocytes collected. The cells were 
washed 3X in saline and then counted for residual radioactivity. 
The distribution of labeled ELX in the tissues of recipients at varying times 
after administration was determined in three separate studies. The results of the 
first two are presented in tabular form (Table III). Although there were minor 
variations in the two experimental designs, the data agree substantially and, 
therefore, have been summed and  averaged. The variations included subcu- 
taneous vs. intraperitoneal route of injection, the use of two different prepara- 
tions of ELX, and the inclusion of 0.5 ml of carrier ALS in one case. Control 
animals received 1~'I labeled NRS IgG in 0.5 ml of whole NRS. The NRS IgG 
was found in highest concentration in the serum at 24 hr and disappeared from 
this compartment with a half-life of about 5.0 days. The distribution in the rest 
of the tissues was roughly related to the organ weight, i.e. liver >  kidneys > 
lungs >  femur >  spleen. At all time intervals, the uptake of ELX in nonlym- 
phoid organs was far less than that for normal rabbit IgG. At 24 hr, the uptake 
of ELX in lymphoid organs (lymph nodes, spleen, and thymus) exceeded that 60  ACTION  OF  ANTI-LYMPHOCYTE SERUM 
of NRS IgG. Since the ratio between serum and tissue levels was so much lower 
in the ELX  group, the observed counts cannot be simply a  reflection of blood 
supply or tissue mass but must represent some specific localizing mechanism. 
TABLE III 
Percentage Distribution of ELY and NRS IgG in the Tissues with Time 
Day 
Tissue 
1  4  12 
Serum* 
Blood 
formed 
elements 
Lymph 
nodes 
Spleen 
Thymus 
Liver 
Kidneys 
Lungs 
Femur 
0.8 
(12.1)$ 
0.2 
(2.0) 
0.3 
(0.25) 
0.33 
(0.16) 
0.08 
(0.06) 
1.20 
(2.30) 
0.80 
(1.10) 
0.26 
(0.70) 
0.13 
(0.37) 
2 
0.3 
(9.1) 
0.02 
(1.07) 
o.12 
(0.25) 
0.09 
(0.18) 
0.02 
(0.10) 
0.33 
(3.50) 
0.15 
(1.50) 
0.07 
(1.10) 
0.05 
(0.40) 
3  6  8  [  10 
i 
0.2  0.1  0.06  0.02  -- 
(7.5)  (3.8) 
0.01  .... 
(1.1)  (0.5)  (0.3) 
(2.4) 
0.04  0.03  0.01  -- 
(0.19)  (0.09)  (0.08) 
0.05  0.03  0.02  0.01 
(0.17)  (0.08)  (0.06) 
0.01  0.01  --  -- 
(0.09)  (0.03)  (0.02) 
0.27  0.27  0.18  0.09  0.05  0.02 
(1.70)  (0.80)  (0.70) 
0.11  0.08  0.04  0.02 
(0.82)  (0.40)  (0.32) 
0.04  0.03  0.01  --  --  -- 
(0.71)  (0.30)  (0.26) 
0.06  0.02  0.02  0.01  --  -- 
(0.34)  (0.21)  0.12) 
:~ Figures m parentheses represent distribution  of NRS IgG. Numbers without parentheses 
are those found for ELX  distribution.  The results are the summed and averaged figures 
for  two different experiments in which two different preparations  were used  (ELX  I  and 
II). Each  figure represents the data from at least 4 individual animals. 
* The values have been corrected for a serum volume of 0.5 ml. 
Over the first 48 hr, the distribution of NRS IgG in the tissues is increasing, 
while at the same time the rate of disappearance of ELX is at a maximum. The 
elimination of ELX from lymphoid organs appears to take place more rapidly 
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The uptake by lymphoid organs of specific antibody is at all times, from 24 hron, 
extremely small. 
Since the bulk of the ELX molecules are eliminated from the body during the 
first 24 hr, the third experiment examined the distribution of ELX at more fre- 
quent intervals during this period. Mice received 80 #g of labeled ELX intra- 
peritoneaUy and were sacrificed at 2, 4, 8, 24, and 48 hr thereafter. The distri- 
bution of the label is depicted in Fig. 8. The peak uptake occurs at 4 hr and the 
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FIO. 8. Showing the percentage distribution of ~I labeled  ELX in the various tissues and 
organs of mice over the first 48 hr after intraperitoneal  injection. 
i I.O 
greatest concentration of antibody is found in the blood where almost 5 % of 
the counts are recovered. The kidney, liver, and spleen contain in decreasing 
frequency another 8 %  between them, while  1%  is recovered in  the pooled 
inguinal, axillary, brachial, and mesenteric nodes, and 0.2 % in the thymus. It 
is apparent that even by 4 hr a good percentage of the radioactivity has been 
cleared from the body and the rate of elimination from the tissues continues at a 
rapid pace until by 48 hr the summed percentage of the injected dose remaining 
in lymphoid organs is about 0.3 %. The label has also been rapidly eliminated 
from nonlymphoid organs and only 0.6 % is present in the serum. 
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in which ELK was labeled with ~5I and injected into recipient mice which were 
killed at intervals and their tissues prepared for radioautography. The tissues 
were fixed in 10% formalin, sections cut from paraffin wax and mounted on 
slides subbed with chromate gelatin. The slides were dipped in Ilford IA emul- 
sion and exposed for 6-8 wk. After development the slides were stained with 
either methyl green pyronine or Congo red. 
In the first experiment ~*6I-labeled ELX was injected intraperitoneally and 
the animals were killed at 2, 4, 8, 24, and 48 hr. The lymph nodes (axillary and 
mesenteric), spleen, thymus, liver, and kidneys were removed and processed 
for radioautography as well as routine histological sections. 
At 2 hr the heaviest concentration of label in lymph nodes was found on and 
about cells in the paracortical area. The true cortex including the germinal 
follicles was relatively spared and contained considerably less label (Fig. 9a, b). 
The label in the spleen was concentrated around the periphery of the Malphi- 
gian follicles (Fig. 10) whereas the thymic label was diffuse and light. In the 
kidney an extremely dense concentration of grains was found in the renal proxi- 
mal tubules but no localization was seen in renal glomeruli or in the liver. 
By 4 hr the intensity of label within lymph nodes had increased but the dis- 
tribution was unchanged. The splenic label was now spread diffusely  throughout 
the cells of the white pulp (Fig. 11) and the renal tubular label was now concen- 
trated on the luminal surface of the cells (Fig. 12). The thymic cortex was some- 
what more heavily labeled than the medulla but  remained relatively light. 
Within the liver, label was clearly localized to the cytoplasm of Kupffer cells 
and was  often associated with the phagocytosis of labeled leukocytes  (Fig. 
13a, b). 
Over the next 40 hr there was a rapid and progressive decrease in the intensity 
of label without any change in the pattern of localization. From 8 hr on, the 
routine sections of lymph nodes showed depletion of small lymphocytes from 
the paracortical areas with evidence of local cell destruction, i.e. presence of 
pale "ghost" cells,  tingible bodies, polymorphonuclear infiltrate, and nuclear 
debris within phagocytic cells (Fig. 14). 
At 48 hr, only a very small amount of label remained in the lymphoid organs 
and was predominantly associated with phagocytes (Fig. 15). 
In the second experiment 20 #g J25I-labeled ELK was mixed with 3 % gelatin 
and injected into the right axilla, subcutaneously. The object was to achieve a 
more localized and  sustained exposure  of the regional lymph nodes and  to 
simulate our usual experimental protocol in which the administration of ALS is 
subcutaneous. The draining, contralateral nodes, spleen, liver, and smears of 
the buffy coat of the blood, were examined at 2, 6, and 24 hr postinjection. At 
2 hr there was very heavy labeling within the marginal sinus and lymph and 
vascular channels of the draining node (Fig. 16). No significant amount of label 
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At 6 hr the label in the draining nodes was largely localized within the para- 
cortical area with sparing of the true cortex as noted before. Some label could 
now be detected in the paracortical area (PCA) of the contralateral nodes and 
within Kupffer cells in the liver (Fig. 17). Approximately 10% of lymphocytes 
in the huffy coat of peripheral  blood were heavily labeled (Fig. 18). Within the 
spleen, label  on lymphoid cells was largely localized to the periphery of the 
lymphoid follicles. At 24 hr considerable cell death was seen in the PCA of the 
draining node (Fig.  19a, b),  but not in either the contralateral nodes or the 
spleen. Label and cell debris was undergoing phagocytosis. The buffy coat cells 
were devoid of label and in the spleen the label was now diffusely spread over 
the white pulp. 
DISCUSSION 
Before any consideration can be given to findings based on the use of ELX, we 
must first be satisfied  that the material recovered  in the manner described 
possesses the same characteristics held by the active fraction in the starting 
material. Antibody  purification  by acid elution has been used by others to study 
the fate and action of specific antibody and has proved to be reliable in other 
models (11, 12). On the other hand, Woodruff (13) has also used acid elution to 
purify ALS and has tested his preparations in vitro. His product retained the 
ability to bind with, agglutinate, and stimulate lymphocytes but had greatly 
reduced cytotoxic properties.  Horse globulin was used in his experiments and 
the acid elution was carried  out at 37°C, whereas  in our experiments  rabbit 
globulin and elution in the cold were used. We do not know if these differences 
in protocol account for the difference in result. 
The antibodies which may attach to the lymphocyte membrane preparation 
only represents  the potentially active fraction. The net active fraction will be 
less, for surely some of these antibodies will be directed to antigens shared be- 
tween lymphocytes and other tissues, and in vivo  may well be absorbed pref- 
erentially elsewhere so that they never come to bear against lymphocytes. An 
improvement might be the absorption of ALS IgG with nonlymphoid tissue 
prior to enrichment. Some denaturation may be a necessary consequence of the 
treatment used,  yet this would appear to be of minor magnitude. Acid-treated 
whole ALS retained in large  parts its biological activity: acid-exposed NRS 
IgG was handled in recipients much like that of unadulterated IgG, and even 
prolonged  acid  exposure  resulted in a  gross denaturation of less  than 20%. 
Moreover, the ELX preparation was a relatively homogeneous solution of IgG 
molecules  and migrated on a  sucrose gradient appropriately. It retained its 
capacity to bind specifically to lymphocytes  antigens and most importantly was 
biologically highly active both in vitro and in vivo. Therefore, it seems reason- 
able to assume that the behavior of this preparation reflects the behavior of 
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These studies strongly suggest that the direct or primary action of a single 
dose of ALS must be quite evanescent  however long its secondary biological 
effects may last. The bulk of injected material is eliminated from the body 
within 24 hr and over 90% is gone in 48 hr. The plot of disappearance  curves 
from the whole body is closely paralleled  by the elimination from the various 
organs and blood stream as well. Evidence from other sources points in the same 
direction. For instance both Pichlmayr et al. (14) and Taub and Ruszkiewicz 
(personal communication)  have followed the disappearance  of cytotoxic anti- 
body from the blood stream after administration of a single dose. While the rate 
of appearance and decay is to some extent related to the route of injection, they 
have found that within a matter of hours cytotoxic antibody can no longer be 
detected. 
When animals are intentionally  preimmunized to ALS IgG then the elimina- 
tion of a subsequent dose of IgG is extremely rapid, often being complete within 
48 hr (15, 16). None the less, it has been shown that even under these circum- 
stances ALS can exert a powerful immunosuppressive  action (2, 4)  although 
there is some diminution of effect. 
The mechanism responsible for the very rapid clearance of active antibody 
eluate found in this study cannot be one of active immunization because, al- 
though ALS IgG is highly immunogenic  (15, 16,  17,  18)  the period  of rapid 
clearance after injection into a virgin animal does not begin for about 6 days 
(15). Up to that point the disappearance  curve parallels that of NRS IgG. De- 
natured material would be expected to be cleared rapidly but the controls in- 
cluded in this study make  gross denaturation unlikely and at any rate this 
explanation  would  fail  to  account  for  the  corroborative  findings  of other 
studies. The most likely explanation  is  that lymphocytes become coated with 
antibody and are either destroyed along with antibody or bring about antibody 
degradation and excretion  some other way. Humphrey (19) has studied the 
clearance  of immune complexes  where antigen and antibody are individually 
labeled,  and has found that both are  simultaneously degraded.  A  question 
which arises is, can the rate of clearance be altered by saturating the system? 
In studies with Jooste (unpublished observations)  ELX was given to weanling 
mice which had been in some cases exposed to a prior dose of ALS. The rate of 
clearance of ELX from the serum under these circumstances  was more rapid 
than that of NRS IgG, but less rapid than in the studies reported above (half- 
life roughly 36 hr.). One possible interpretation is that the smaller number of 
available lymphocytes resulted  in a  diminished  number of binding sites  for 
passive clearance. 
Although ELX molecules are found to localize within lymphoid tissue to a 
greater extent than would be expected if they did not possess an affinity for 
lymphoid antigens, the amount of antibody uptake involves only a minor frac- 
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at peak concentration is less than that present in the blood at the same time. 
Considering that there are fewer lymphocytes in the blood than in lymphoid 
tissue it is clear that the ratio of antibody to cells is far greater in the blood 
than within lymphoid tissue. Furthermore, the antibody is cleared from lym- 
phoid organs pari passu with the clearance  from other organs  and from the 
whole body. Although the antisera from which ELX was prepared were raised 
against thymocytes  and thymocyte  membrane was used in the absorption step, 
the specific uptake into the  thymus remains quite low. When compared with 
nonlymphoid  tissue  (femur, lung) the uptake is comparable, but when compared 
with spleen or lymph node the uptake is far less. We construe this observation 
as additional indication that access of antibody to thymocytes in vivo is re- 
stricted. Hintz and Webber  (21) and Denman and Frenkel (22) have studied 
the localization  of ALS within the tissues  of recipients  using the entire IgG 
fraction and compared  the uptake with that of NRS IgG. Their studies have 
the same inherent limitations as the similar studies we undertook before turn- 
ing to the use of purified antibody (see above). Both authors found very little 
uptake of ALS IgG antibody molecules within lymphoid organs. 
The radioautographic studies reported here suggest that there is an unequal 
partition of antibody within lymphoid tissue.  The greatest concentration of 
label occurred within  and around the vascular channels in the paracortical areas 
of the lymph nodes. These are precisely the areas which are subject to lymphoid 
depletion after ALS  administration (23-26).  In the spleen  the label  is first 
heaviest around ceils in the periphery of the white pulp follicles but later is 
found rather diffusely throughout the follicle. The true cortex of lymph nodes 
was relatively spared although it is true that to some extent antibody was dis- 
tributed throughout lymphoid tissue. Levey and Medawar (4) have also shown 
by fluorescent labeling techniques that ALS is able to coat lymphoid cells within 
organs in vivo. However, they did not determine to what extent the label rep- 
resented nonantibody protein. The reason for this inequality in tissue localiza- 
tion is not entirely dear, however;  at least three possibilities  exist. The first 
presupposes that antibody selects sites of binding because the antigenic makeup 
of the cells varies within lymphoid tissue, and the cells in the paracortical area 
are more congenial. This explanation is unlikely since, other things being equal 
one would expect  the highest concentration of label in the thymus which is 
dearly not the case. Another possibility  is that the antibody molecules are 
found most heavily concentrated in those areas where the blood supply is the 
greatest. Ceils lying close to the path of diffusion would have the opportunity to 
accumulate larger amounts of antibody than those lying at some distance. The 
difficulty  with this explanation is, again, that the thymus is at least as vascular 
as lymph nodes; furthermore, it is hard to see how the change in splenic localiza- 
tion with time could be explained on this basis. A third possibility is that the 
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cells in the recirculating  pool  (27). The supposition here is that the cells may 
have been heavily coated in the blood stream or lymph prior to entry into the 
lymphoid tissue. 
The reason  why cells in the thymus, lymph nodes,  and spleen which  are 
coated with antibody are not destroyed is also not entirely clear but a number 
of factors may come into play. Humphrey and Dourmashkin  2 have shown that 
for lysis of erythrocytes  to be brought about by IgG antibody, about a thousand 
molecules must attach to the same cell. Woodruff et al. (3) have calculated that 
each lymphocyte  can take up as many as 5.0 X  106 molecules on its surface but 
the exact number required for lysis is not known. Therefore, although lympho- 
cytes in lymphoid tissue are exposed to IgG antibody the concentration may 
not be sufficient to cause irreversible damage. Another limiting factor might be 
the local availability of complement.  As early as 1961, Waksman et al. (28) 
showed that after the administration of ALS there was a drop in the circulating 
complement levels. If, as is widely believed,  complement  is necessary for the 
direct immune destruction of cells (29, 30) then a limited availability of com- 
plement within lymphoid tissue might explain the relative protection these ceils 
receive. A third possibility is that ceils in the circulation when coated with anti- 
body become opsonized and subject to phagocytosis by the cells of the RE sys- 
tem, (31, 32) but that within lymphoid tissue, coated lymphocytes are not ex- 
posed to these phagocytic cells to the same extent. Finally, one may draw the 
analogy to the rather similar phenomenon well known to those who have at- 
tempted to destroy tumor growths with antibody. While antibody may inhibit 
the growth of dissociated  ceils, they are ineffective or enhance  the growth of 
solid tumor (33-35).  At any rate, the exact explanation for this phenomenon 
will have to await further experimentation. 
These findings cast grave doubts on the tenability of those hypotheses con- 
cerning the action of ALS which postulate the persistence of antibody molecules 
in the recipient. For instance, "blindfolding" (4, 36, 37), in which the lympho- 
cytes are thought to be rendered  incompetent because their receptor  sites are 
covered  by antibody, requires that an antibody coat persists  throughout the 
period of incompetence.  Similarly a peripheral  enhancement mechanism (38) 
requires that significant amounts of antibody persist to coat graft antigen dur- 
ing the period of graft protection. In view of the rapid disappearance  of anti- 
body from the body and the very prolonged effects which may follow even a 
single dose of ALS these mechanisms become very improbable. These results do 
lend support to the evidence that ALS coats circulating lymphocytes  and causes 
their removal from the circulation  by the cells of the  reticuloendothelial  sys- 
tem, predominantly the liver (26). They also help to explain the relative pro- 
tection enjoyed by cells within lymphoid tissue (39) and provide some explana- 
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tion for the selective anatomical lesion caused within lymphoid organs (23-26). 
All in all they are in accord with the hypothesis that ALS achieves its immuno- 
suppressive  effect by bringing  about a selective ablation of the population of 
recirculating lymphocytes (25). 
These findings also bear upon the practical considerations of timing and dos- 
age of ALS as applied to clinical use. For instance,  it becomes clear that any 
schedule of administration in man will have to be predicated on a knowledge 
both of the turnover time of the recirculating  pool of lymphocytes and of the 
effective rate of clearance of the specific active component of anti-human ALS. 
SUMMARY 
Studies designed to gain insight into the mechanism of action of the active 
component of antllymphocyte  serum were carried out using an antibody eluate 
prepared from the IgG fraction of anti-lymphocyte serum by absorption and 
subsequent elution from thymocyte membrane. The resulting antibody eluate 
was labeled with radionuclide  tracer to determine the fate of the antibody in 
vivo. The result indicated that anti-lymphocytic  antibodies are eliminated from 
recipients  extremely rapidly. The mechanism for this rapid clearance appears 
to depend upon the absorption of antibody molecules onto lymphocyte  surfaces 
and the subsequent clearing and degradation of the antibody-lymphocyte  com- 
plexes by the reticuloendothelial system. 
Distribution studies confirm  that the major site of antibody-lymphocyte 
interaction occurs in the periphery with relatively little penetration of anti- 
body  within  lymphoid organs.  Radioautographic  studies  showed  that  the 
pattern of localization within lymphoid and other organs is confined to rather 
specific areas.  These observations  are believed to offer strong support for the 
notion that anti-lymphocyte serum achieves its immunosuppressive  effect by 
bringing about a selective ablation of the population of recirculating  lympho- 
cytes. 
We thank Miss Ruth Sharman and Vee Margolis for their excellent technical assistance. 
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antilymphocytic antiserum. Proc. Nat. Acad.  Sci. U.S.A. 58:470. FIo. 9a. Axillary lymph node at 4 hr. Note the heavy label relatively circumscribed 
to the paracortical area with sparing of the cortex. (X  325) 
FIG. 9b. Higher magnification of paracortical area showing labeling of all cells. Note 
the greater intensity of label within the vascular channel. (X  620) 
70 FIG. 10. Spleen at 2 hr. Arrow indicates a central arteriole. Note the heavy concen- 
tration of label associated with ceils at the periphery of the Malphigian follicle.  (× 
365) 
FIG. 11. Splenic white pulp at 4 hr. The label is diffusely spread over cells but clumps 
of label are already found in the cytoplasm of reticular cells. (>(740) 
71 FIG. 12. Kidney at 4 hr. Note the very dense label in the proximal tubules and the 
sparing of glomeruli and other tubular components. (X  125) 
FIG. 13. Routine section of an axillary lymph node 48 hr after ELX. Note the deple- 
tion of the PCA as contrasted with the cortex. (H and E  X  210) 
72 FIG. 14a, b. Two identical fields of the liver at 4 hr; a is focused on the cells and  b on 
the grains. Within the Kupffer cells are phagocytosed leukocytes and in figure  14b it 
can be appreciated  that it is these cells which are heavily labeled.  (×  1200) 
73 FIG. 15.  Splenic white pulp at 48 hr. Note the marked decrease in label with that 
remaining associated with phagocytosis. (X 485) 
FIG. 16. Draining lymph node 2 hr after subcutaneous injection of ELX 125I. There 
is a heavy concentration of label in the marginal sinus. (X  1200) 
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FIG. 17. Liver 6 hr after ELX 125I subcutaneously. Note the specific localization of 
label within the cytoplasm o[ Kupffer cells. (X  1200) 
FIG. 18. Labeled lymphocytes found in the peripheral blood smear at 6 hr. (X 2050) FIG. 19a. Paracortical area of an axillary lymph node at 24 hr. Lymphoid cell deple- 
tion is already evident and many pale necrobiofic cells are seen. The general intensity 
of labeling is decreasing. (N 485) 
FIo.  19b. Axillary lymph node 24 hr after  intraperitoneal  injection  of  i~I  NRS 
IgG. Contrast the cellularity and localization of label with Fig. 19a.  (X 485) 
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